Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis.
about
Microbial translocation in chronic liver diseasesNon-alcoholic fatty liver disease: what the clinician needs to know.An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree miceThe Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver DiseaseThe role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver diseaseLeaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitisObesity, fatty liver disease and intestinal microbiotaCo-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: A review articleGut Microbiota and Host Reaction in Liver DiseasesGut Microbiota and Complications of Liver Disease.Lipopolysaccharide-binding protein is associated with arterial stiffness in patients with type 2 diabetes: a cross-sectional study.Fecal microbiota transplantation in metabolic syndrome: History, present and future.A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy ChineseMicrobiome of prebiotic-treated mice reveals novel targets involved in host response during obesityDeterminants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesityA gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome.Nonalcoholic fatty liver disease: for better or worse, blame the gut microbiota?Gut microbiota-based translational biomarkers to prevent metabolic syndrome via nutritional modulationReduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model.Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.Risks of misinterpretation in the evaluation of the effect of fruit-based drinks in postprandial studies.What does irritable bowel syndrome share with non-alcoholic fatty liver disease?Hepatocellular proliferation correlates with inflammatory cell and cytokine changes in a murine model of nonalchoholic fatty liver diseaseImplication of gut microbiota in nonalcoholic fatty liver disease.Meta-omic platforms to assist in the understanding of NAFLD gut microbiota alterations: tools and applications.Hematological and acute-phase responses to diet-induced obesity in IL-6 KO mice.Non-alcoholic fatty liver disease, diet and gut microbiota.Chronic Endotoxemia in Subjects with Type-1 Diabetes Is Seen Much before the Onset of Microvascular Complications.Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice.Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota.Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLDHigh Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments.ER stress induces NLRP3 inflammasome activation and hepatocyte death.Microbial translocation across the GI tractFemale mice are more susceptible to nonalcoholic fatty liver disease: sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, but not the hepatic endotoxin response.Misregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity.Subclinical-Dose Endotoxin Sustains Low-Grade Inflammation and Exacerbates Steatohepatitis in High-Fat Diet-Fed Mice.Association of Lipopolysaccharide-Binding Protein With Aging-Related Adiposity Change and Prediabetes Among African Ancestry MenCirculating Soluble CD163 is Associated with Steatohepatitis and Advanced Fibrosis in Nonalcoholic Fatty Liver DiseaseLipopolysaccharide Disrupts Mitochondrial Physiology in Skeletal Muscle via Disparate Effects on Sphingolipid Metabolism.
P2860
Q21284997-FB972AF9-F6A4-4382-BAF7-82369348A852Q24563068-82AF5F76-2310-4BB0-BDE0-B8940CEC4A89Q24601321-EDF86B47-FD8D-4F57-AF7A-A61389EE433CQ26780509-8EFBABAF-353E-4AE9-A90B-A97AFFBB7932Q26852498-FA65F2D9-449D-4238-B518-A3EA1433EF93Q26991664-BE83A157-C8D2-4856-82A3-29C44DABF572Q26997784-90E7E5A4-FAD4-45B6-95FC-BC178554888AQ28076892-D78FBD73-BC77-4FE8-8D00-565D540C9658Q28083295-1C088A25-2A71-42A4-9BA6-E1AA2E1953D9Q30236024-F2156A1A-6E4A-42B0-85D2-7EA0CB40D099Q33655219-D77E025E-E773-462C-B25C-A5139538E6FBQ33821397-1D1E3D58-DC9A-4C8A-993B-D82738215FCEQ34084463-6F081A34-9613-4E51-B22C-852D3D048095Q34175068-98EC16C5-A2F3-4F9E-94AC-5A51C7B0BA57Q34563341-07E29AC3-3A8A-4547-A0D2-D409D1070EA5Q34629179-FC40D782-D73B-4175-8BA1-4E30459178F1Q34641213-B04DB19D-6910-4256-A821-368179B97572Q34669782-ACBED5C3-1DF9-4E20-87FA-7A5CF2347E23Q34731373-59E877CF-2F1E-48DE-AE64-099DE4CC370EQ34779049-C3129E91-0902-478A-AA0A-72771313D3BAQ34970620-0B159826-B0C7-49DF-A1CA-198199F5DD4CQ34983471-E880EF95-33EA-4E69-A659-B1E0C2B69978Q34988788-BFFCBF10-09C6-460B-8383-5A79E31BAA14Q35019282-F69BB532-7317-4999-B1A2-A07E01CD4A4EQ35084719-BE766B4C-4619-4288-B18E-CF99167DC3B6Q35566549-73D77D56-E7DF-4A60-996E-287A55D15202Q35728214-536E6B72-75E2-4404-8D02-4A7C3C4229DAQ35773292-D7A9B40D-CBC2-487C-88B7-31961F45BC42Q35825858-2D2CEA62-BD2F-44F9-BB8C-5B86AE1E5FC0Q36148926-9BAD1A96-19AC-413F-A6A3-5601D1C86832Q36228033-99FBEE27-1804-4000-941D-9A3F28164EC5Q36255749-C374C476-3B83-406B-B255-033C0235744BQ36293033-31DC71EE-683A-409A-A31E-BCDB7EED1E96Q36441742-2CA7CC78-1828-4E99-AE3D-0141EBBF6505Q36465264-6F3CDBCF-0675-4170-8F0C-1B4B7CD263C1Q36478196-1F290646-4C5A-4F24-A268-1D5B269C2FA1Q36600936-0912726D-4A91-4350-BF73-9B27D9D52D6DQ36608408-9242E264-F585-44AC-83EA-104B252C313EQ36751382-DDCEC35C-8E99-4E08-BE00-6D57C248795EQ36852279-CA4975D0-280C-43D3-B108-3FE83E9A3901
P2860
Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Lipopolysaccharide-binding pro ...... non-alcoholic steatohepatitis.
@ast
Lipopolysaccharide-binding pro ...... non-alcoholic steatohepatitis.
@en
Lipopolysaccharide-binding pro ...... non-alcoholic steatohepatitis.
@nl
type
label
Lipopolysaccharide-binding pro ...... non-alcoholic steatohepatitis.
@ast
Lipopolysaccharide-binding pro ...... non-alcoholic steatohepatitis.
@en
Lipopolysaccharide-binding pro ...... non-alcoholic steatohepatitis.
@nl
prefLabel
Lipopolysaccharide-binding pro ...... non-alcoholic steatohepatitis.
@ast
Lipopolysaccharide-binding pro ...... non-alcoholic steatohepatitis.
@en
Lipopolysaccharide-binding pro ...... non-alcoholic steatohepatitis.
@nl
P2093
P2860
P921
P1433
P1476
Lipopolysaccharide-binding pro ...... non-alcoholic steatohepatitis.
@en
P2093
Amalia Cayón
Angel Estebanez
Armando Guerra Ruiz
Fernando Pons-Romero
Javier Crespo
José Carlos Fernadez-Escalante
Marta Mayorga
P2860
P2888
P304
P356
10.1007/S11695-007-9243-7
P577
2007-10-01T00:00:00Z